Zephyr AI
McLean, United States· Est.
Zephyr AI leverages machine learning to discover novel therapeutics and biomarkers for oncology and metabolic diseases.
Private Company
Total funding raised: $129.5M
About
Zephyr AI leverages machine learning to discover novel therapeutics and biomarkers for oncology and metabolic diseases.
AI / Machine LearningOncologyMetabolic
Funding History
2Total raised:$129.5M
Series A$111M
Seed$18.5M